Desmoid tumors can present management challenges due to their unpredictable behavior. Steven I. Robinson, MBBS, an associate professor of oncology and medical oncologist at the Ma ...
Dr Daniel Petrylak discusses groundbreaking advancements in prostate cancer treatment, including genetic mutations, PARP ...
A machine learning model enhances treatment decisions for hepatocellular carcinoma, optimizing survival outcomes through ...
2. Ferrarotto R, Anderson I, Medgyasszay B, et al. Trilaciclib prior to chemotherapy reduces the usage of supportive care ...
New findings reveal tarlatamab combined with anti–PD-L1 agents significantly improves survival in extensive-stage small cell ...
Innovative treatments like JAK2 inhibitors and bispecific antibodies show promise in overcoming immunotherapy resistance in non-small cell lung cancer.
An expert discusses emerging frontline treatments for EGFR-mutated non–small cell lung cancer (NSCLC), highlighting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback